Vitamin Shoppe Inc is in the retail apparel and specialty industry and is in the consumer cyclical sector. The company CEO is Sharon M. Leite. Vitamin Shoppe Inc is a specialty retailer and contract manufacturer of nutritional products. It offers vitamins, minerals, specialty supplements, herbs, sports nutrition, under brands such as The Vitamin Shoppe, BodyTech, True Athlete, and MyTrition.
Previous Intraday Trading Performance:
The VSI stock showed a previous change of -2.60% with an open at 6.93 and a close of 6.74. It reached an intraday high of 6.93 and a low of 6.71.
The stock has a market cap of $161.8m with 24.0m shares outstanding, of which the float is 13.9m shares. Trading volume reached 231,676 shares compared to its average volume of 521,045 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.
Historical Trading Performance:
Over the last five trading days, Vitamin Shoppe Inc shares returned -6.91% and in the past 30 trading days it returned -8.17%. Over three months, it changed 30.62%. In one year it has changed 62.41% and within that year its 52-week high was 13.95 and its 52-week low was 3.95. VSI stock is 70.63% above its 52 Week Low.
Our calculations show a 200 day moving average of 7.89 and a 50 day moving average of 6.47. Currently VSI stock is trading -14.56% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
The last annual fiscal EPS for the company was reported at -0.17 that ended on 31st of December 2018.The TTM EPS is 0.26, which comes to a TTM PE of 25.92.
Base on our calculations, the intrinsic value per share is 33.45, which means it is possibly undervalued and has a margin of safety of 79.85%
Indicators to Watch:
Based on the latest filings, there is 133.10% of institutional ownership. Short-interest is 3,940,391, which is 16.41% of shares outstanding. The short-interest ratio or days-to-cover ratio is 7.27. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.
The current calculated beta is 1.41
Based on last reported financials, the company’s return on equity is -2.00%, return on assets is -0.87%, profit margin is -0.02%, price-to-sales is 0.25 and price-to-book is 0.92.
All scores are out of six:
5 :Valuation Score
0 :Past Performance Score
4 :Financial Strength Score
0 :Future Growth Score
0 :Dividend Score
2 :Overall Score